The role of CDK4, CDK2 and CDK1 in KRas driven lung tumors: The good, the bad and the ugly

Date 23 March 2018
Event ESMO Symposium on Signalling Pathways in Cancer 2018
Session The concept of CDK inhibition according to the targeted CDK subtype
Topics Pathology/Molecular Biology
Presenter Mariano Barbacid
Authors M. Barbacid
  • -, CNIO- Spanish National Cancer Center, 28029 - Madrid/ES